Detailed Information
Cited 0 time in 
Cited 3 time in 
Cited 3 time in
Metadata Downloads
Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial
- Authors
- Han, Eugene; Huh, Ji Hye; Lee, Eun Y.; Bae, Ji C.; Chun, Sung W.; Yu, Sung H.; Kwak, Soo H.; Park, Kyong S.; Lee, Byung-Wan
- Issue Date
- Apr-2022
- Publisher
- Blackwell Publishing Inc.
- Keywords
- dipeptidyl peptidase-4 inhibitor; evogliptin; magnetic resonance imaging-derived proton density fat fraction; non-alcoholic fatty liver disease; pioglitazone; type 2 diabetes
- Citation
- Diabetes, Obesity and Metabolism, v.24, no.4, pp 752 - 756
- Pages
- 5
- Journal Title
- Diabetes, Obesity and Metabolism
- Volume
- 24
- Number
- 4
- Start Page
- 752
- End Page
- 756
- ISSN
- 1462-8902
1463-1326
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Chun, Sung Wan
- College of Medicine (Department of Internal Medicine)